The Enterprise Value as of December 2025 (TTM) for Larimar Therapeutics, Inc. (LRMR) is 299.00M

According to Larimar Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 299.00M. This represents a change of 33.27% compared to the average of 224.35M of the last 4 quarters.

Larimar Therapeutics, Inc. (LRMR) Historical Enterprise Value (quarterly & annually)

How has LRMR Enterprise Value performed in the past?

The mean historical Enterprise Value of Larimar Therapeutics, Inc. over the last ten years is 134.21M. The current 299.00M Enterprise Value has changed 22.18% with respect to the historical average. Over the past ten years (40 quarters), LRMR's Enterprise Value was at its highest in in the September 2015 quarter at 1.01B. The Enterprise Value was at its lowest in in the September 2022 quarter at -9351670.40.

Larimar Therapeutics, Inc. (LRMR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Larimar Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Larimar Therapeutics, Inc. (LRMR) Average Enterprise Value

How has LRMR Enterprise Value performed in the past?

The current Enterprise Value of Larimar Therapeutics, Inc. (LRMR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Larimar Therapeutics, Inc. (LRMR) Enterprise Value vs. Peers

How is LRMR’s Enterprise Value compared to its peers?

Larimar Therapeutics, Inc.’s Enterprise Value is less than enGene Holdings Inc. (396.46M), less than Annexon, Inc. (432.32M), less than DBV Technologies S.A. (361.47M), greater than Amarin Corporation plc (224.37M), less than Altimmune, Inc. (407.41M), greater than Kyverna Therapeutics, Inc. (295.80M), greater than Korro Bio, Inc. (74.88M), greater than Alto Neuroscience, Inc. (272.30M), less than Lexeo Therapeutics, Inc. Common Stock (636.88M), greater than AC Immune S.A. (211.85M),

Build a custom stock screener for Larimar Therapeutics, Inc. (LRMR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Larimar Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Larimar Therapeutics, Inc. (LRMR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Larimar Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.